Evidence map›Paper›PMID 28352984›Full record

ArticleAIDS and behavior2017

A Longitudinal Analysis of Treatment Optimism and HIV Acquisition and Transmission Risk Behaviors Among Black Men Who Have Sex with Men in HPTN 061.

Matthew E Levy, Gregory Phillips, Manya Magnus, Irene Kuo, Geetha Beauchamp, Lynda Emel, Christopher Hucks-Ortiz, Erica L Hamilton, Leo Wilton, Iris Chen and 7 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. General regression methods for respondent-driven sampling data.Statistical methods in medical research · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Matthew E LevyDepartment of Epidemiology and Biostatistics, Milken Institute School of Public Health at the George Washington University, 950 New Hampshire Ave NW, 5th Floor, Washington, DC, USA. mattelevy@gwu.edu.
Gregory PhillipsDepartment of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Manya MagnusDepartment of Epidemiology and Biostatistics, Milken Institute School of Public Health at the George Washington University, 950 New Hampshire Ave NW, 5th Floor, Washington, DC, USA.
Irene KuoDepartment of Epidemiology and Biostatistics, Milken Institute School of Public Health at the George Washington University, 950 New Hampshire Ave NW, 5th Floor, Washington, DC, USA.
Geetha BeauchampVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Lynda EmelVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Christopher Hucks-OrtizDivision of HIV Prevention and Care, John Wesley Community Health Institute, Los Angeles, CA, USA.
Erica L HamiltonScience Facilitation Department, FHI 360, Durham, NC, USA.
Leo WiltonDepartment of Human Development, State University of New York at Binghamton, Binghamton, NY, USA.
Iris ChenDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sharon MannheimerDepartment of Medicine, Harlem Hospital and Columbia University Medical Center, New York, NY, USA.
Hong-Van TieuLaboratory of Infectious Disease Prevention, New York Blood Center, New York, NY, USA.
Hyman ScottBridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA.
Sheldon D FieldsNicole Weirtheim College of Nursing and Health Sciences, Florida International University, Miami, FL, USA.
Carlos Del RioDepartment of Global Health, Rollins School of Public Health, Atlanta, GA, USA.
Steven ShoptawDepartment of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Kenneth MayerFenway Health, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, MA, USA.

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ARTHUR Y KIM · 2004 to 2026
$94.4M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Harvard Medical School Vaccine Clinical Trials UnitUM1AI069412 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Lindsey Robert Baden, Daniel R. Kuritzkes · 2012 to 2026
$57.2M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI SEBLE G KASSAYE · 2015 to 2026
$29.6M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
National Center for Research Resources UL1 RR025008National Institute of Allergy and Infectious Diseases 3U01 AI069466-03S1National Institute of Allergy and Infectious Diseases 3U01 AI069496-03S1National Institute of Allergy and Infectious Diseases 3U01 AI069496-03S2National Institute of Allergy and Infectious Diseases 5U01 AI069418National Institute of Allergy and Infectious Diseases 5U01 AI069466National Institute of Allergy and Infectious Diseases P30 AI050409National Institute of Allergy and Infectious Diseases P30 AI060354National Institute of Allergy and Infectious Diseases P30 AI087714National Institute of Allergy and Infectious Diseases P30 MH058107National Institute of Allergy and Infectious Diseases U01 AI069424National Institute of Allergy and Infectious Diseases UM1 AI068613National Institute of Allergy and Infectious Diseases UM1 AI068617National Institute of Allergy and Infectious Diseases UM1 AI068619National Institute of Allergy and Infectious Diseases UM1 AI069480NCATS NIH HHS UL1 TR000454NCATS NIH HHS UL1 TR002378NCRR NIH HHS UL1 RR025008NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI060354NIAID NIH HHS P30 AI087714NIAID NIH HHS P30 AI117970NIAID NIH HHS U01 AI069418NIAID NIH HHS U01 AI069424NIAID NIH HHS U01 AI069466NIAID NIH HHS U01 AI069496NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069412NIAID NIH HHS UM1 AI069480NIAID NIH HHS UM1 AI069496NICHD NIH HHS R25 HD045810NIMH NIH HHS P30 MH058107NIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

Little is known about HIV treatment optimism and risk behaviors among Black men who have sex with men (BMSM). Using longitudinal data from BMSM in the HPTN 061 study, we examined participants' self-reported comfort with having condomless sex due to optimistic beliefs regarding HIV treatment. We assessed correlates of treatment optimism and its association with subsequent risk behaviors for HIV acquisition or transmission using multivariable logistic regression with generalized estimating equations. Independent correlates of treatment optimism included age ≥35 years, annual household income <$20,000, depressive symptoms, high HIV conspiracy beliefs, problematic alcohol use, and previous HIV diagnosis. Treatment optimism was independently associated with subsequent condomless anal sex with a male partner of serodiscordant/unknown HIV status among HIV-infected men, but this association was not statistically significant among HIV-uninfected men. HIV providers should engage men in counseling conversations to assess and minimize willingness to have condomless sex that is rooted in optimistic treatment beliefs without knowledge of viral suppression.

Indexed as

CondomsRisk-TakingAdultAge FactorsBlack or African AmericanDepressionHIV InfectionsHomosexuality, MaleHumansLogistic ModelsLongitudinal StudiesMaleMiddle AgedSexual PartnersSocioeconomic FactorsBlack men who have sex with menCondom useHIVSexual risk behaviorsTreatment optimism

Identifiers

PMID28352984
PMCPMC5623129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.